Fresenius Kabi Canada Revenue and Competitors
Estimated Revenue & Valuation
- Fresenius Kabi Canada's estimated annual revenue is currently $41.4M per year.
- Fresenius Kabi Canada's estimated revenue per employee is $201,000
Employee Data
- Fresenius Kabi Canada has 206 Employees.
- Fresenius Kabi Canada grew their employee count by 14% last year.
Fresenius Kabi Canada Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $18.7M | 93 | 16% | N/A | N/A |
#2 | $12.3M | 61 | 27% | N/A | N/A |
#3 | $6.6M | 33 | 38% | N/A | N/A |
#4 | $17.9M | 93 | 3% | $192.2M | N/A |
#5 | $62.3M | 310 | 9% | N/A | N/A |
#6 | $0.5M | 5 | -55% | N/A | N/A |
#7 | $11.7M | 58 | 29% | N/A | N/A |
#8 | $2.3M | 23 | 109% | N/A | N/A |
#9 | $1157M | 5756 | -17% | N/A | N/A |
#10 | $41.4M | 206 | 14% | N/A | N/A |
What Is Fresenius Kabi Canada?
Fresenius Kabi is a leading global health care company focusing on products for the therapy and care of critically and chronically ill patients inside and outside the hospital. We develop, produce and market pharmaceuticals and medical devices. Fresenius Kabi Canada is a diverse pharmaceutical company committed to supplying high quality, cost-effective pharmaceutical products and services to Canadians. Our product portfolio includes intravenous specialty and generic medicines, transfusion technologies, infusion therapies, parenteral nutrition and related medical devices. With our corporate philosophy of caring for life, we are dedicated to improving patient quality of life by putting essential medicines and technologies in the hands of people who help patients across Canada. Our Canadian Headquarters is located in Toronto. We offer our employees comprehensive company paid benefits, a company matched RRSP, a generous vacation plan and competitive compensation. Join a growing team that makes a difference.
keywords:N/AN/A
Total Funding
206
Number of Employees
$41.4M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fresenius Kabi Canada News
Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals, ... North America (USA and Canada)
Astrazeneca; Fresenius-Kabi; AbbVie; Baxter Healthcare ... North America (United States, Canada and Mexico); Europe (Germany, France, United Kingdom,...
Par Pharmaceutical, Pfizer, Novartis, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals.
AstraZeneca, Fresenius-Kabi, BbVie Laboratories, Baxter Healthcare, ... Geographical Analysis: North America, United States, Canada, Mexico, ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $73.2M | 206 | 2% | N/A |
#2 | N/A | 206 | 32% | N/A |
#3 | $57.6M | 207 | 4% | N/A |
#4 | $61.5M | 207 | 2% | N/A |
#5 | $61.8M | 208 | 11% | N/A |
Fresenius Kabi Canada Executives
Name | Title |
---|---|
Mona Said | Executive Assistant To Chief Executive Officer |
Martin Willner | Executive Vice President |
Parminder Punia | Vice President Corpoate Services |